Sherif F El-Khamisy Selected Research

Aftercare (After-Treatment)

9/2018

Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sherif F El-Khamisy Research Topics

Disease

19	Neoplasms (Cancer) 11/2023 - 03/2014
7	Genomic Instability 01/2023 - 01/2018
5	Nervous System Diseases (Neurological Disorders) 01/2024 - 10/2006
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2005
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2015
3	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 01/2015
3	Hypersensitivity (Allergy) 01/2021 - 03/2014
3	Alzheimer Disease (Alzheimer's Disease) 12/2018 - 04/2016
3	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 01/2018 - 01/2013
3	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 02/2010 - 03/2005
2	Glioblastoma (Glioblastoma Multiforme) 02/2021 - 03/2014
2	Inborn Genetic Diseases (Disease, Hereditary) 09/2019 - 02/2010
2	Chromosome Breakage 12/2018 - 04/2004
2	Ataxia (Dyssynergia) 01/2018 - 05/2014
2	Early-onset ataxia with oculomotor apraxia and hypoalbuminemia 06/2009 - 03/2009
1	Triple Negative Breast Neoplasms 01/2023
1	Huntington Disease (Huntington's Disease) 02/2022
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2022
1	Hyperthermia 05/2021
1	Glioma (Gliomas) 02/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2020
1	Acute Promyelocytic Leukemia 02/2019
1	Leukemia 02/2019
1	Rhabdomyosarcoma 12/2018
1	Melanoma (Melanoma, Malignant) 10/2018
1	Infections 06/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2017
1	Cardiotoxicity 01/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2014
1	Intellectual Disability (Idiocy) 05/2014
1	Seizures (Absence Seizure) 05/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2013
1	Neuroblastoma 05/2007

Drug/Important Bio-Agent (IBA)

19	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2004
10	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2004
5	tyrosyl-DNA phosphodiesteraseIBA 12/2018 - 02/2010
4	Type I DNA Topoisomerases (Topoisomerase I)IBA 02/2022 - 02/2010
4	EnzymesIBA 11/2021 - 02/2010
4	PoisonsIBA 05/2021 - 07/2014
4	Biomarkers (Surrogate Marker)IBA 02/2019 - 02/2015
3	taxaneIBA 12/2021 - 01/2015
3	A-Form DNA (A-DNA)IBA 02/2021 - 05/2007
3	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 07/2018
2	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2021
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 05/2021 - 03/2005
2	Temozolomide (Temodar)FDA LinkGeneric 02/2021 - 03/2014
2	Nucleic AcidsIBA 09/2019 - 01/2018
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 02/2015
2	Adenosine Monophosphate (AMP)IBA 06/2009 - 03/2009
1	Glycoproteins (Glycoprotein)IBA 11/2023
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	PlatinumIBA 01/2022
1	Ribosomal DNA (rDNA)IBA 01/2022
1	RNA Polymerase I (Polymerase I, RNA)IBA 01/2022
1	EndonucleasesIBA 11/2021
1	Histones (Histone)IBA 10/2021
1	DipeptidesIBA 08/2021
1	Messenger RNA (mRNA)IBA 02/2021
1	Small Interfering RNA (siRNA)IBA 02/2021
1	DNA HelicasesIBA 01/2021
1	NucleosidesIBA 01/2020
1	nasIBA 09/2019
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 02/2019
1	trans-sodium crocetinate (crocetin)IBA 02/2019
1	Histone Deacetylase 1IBA 02/2019
1	Melanins (Melanin)IBA 10/2018
1	SofosbuvirIBA 09/2018
1	Antiviral Agents (Antivirals)IBA 09/2018
1	GoldIBA 01/2018
1	Free RadicalsIBA 04/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Harmine (Telepathine)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	CamptothecinIBA 01/2016
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2016
1	Peptides (Polypeptides)IBA 02/2015
1	Indicators and Reagents (Reagents)IBA 07/2014
1	Topotecan (Hycamtin)FDA LinkGeneric 07/2014
1	Deoxyribonuclease I (Nickase)IBA 03/2014
1	Alkylating AgentsIBA 03/2014
1	Protein Kinases (Protein Kinase)IBA 04/2004

Therapy/Procedure

14	Therapeutics 11/2023 - 03/2014
3	Drug Therapy (Chemotherapy) 05/2021 - 07/2014
2	Radiotherapy 05/2021 - 03/2020
2	Ligation 03/2009 - 10/2006
1	Aftercare (After-Treatment) 09/2018